Wharton Jelly Mesenchymal stem cells

BIOLOGICAL4 trials

Sponsors

Sophia Al-Adwan, Hanan Jafar

Conditions

Diabetic NephropathiesErectile Dysfunction Associated With Type 2 Diabetes MellitusInflammatory Bowel Diseases

Phase 1

Safety of Wharton Jelly in Erectile Dysfunction

CompletedNCT02945449

Sophia Al-AdwanErectile Dysfunction Associated With Type 2 Diabetes Mellitus

Start: 2017-01-04End: 2018-11-30Updated: 2018-11-15

Use of Wharton Jelly in Diabetic Nephropathy

Sophia Al-AdwanDiabetic Nephropathies

Start: 2019-11-30End: 2021-01-31Target: 20Updated: 2019-07-24

Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease

Hanan JafarInflammatory Bowel Diseases

Start: 2017-06-05End: 2020-01-31Target: 20Updated: 2019-04-10

Efficacy of Wharton Jelly in Erectile Dysfunction

CompletedNCT03751735

Sophia Al-AdwanErectile Dysfunction Associated With Type 2 Diabetes Mellitus

Start: 2017-01-27End: 2019-02-26Updated: 2019-04-10

Related Papers

Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical Trial

Urologia Internationalis2021-01-0135 citations